Positieve testresultaten voor de NovioSense Glucose Sensor!

01 / 11 / 18

Positieve testresultaten voor de NovioSense Glucose Sensor!

In the media
01 / 11 / 18

Dr. Wilson, NovioSense’s CEO, told the magazine Businesswire: “Today marks an important step in our tear glucose program. We opted to deploy the tear glucose sensor in diabetic patients to obtain evidence that tear glucose levels may be utilised to predict blood glucose levels with a clinically acceptable accuracy.”

 

Read the entire article here!